eaVision Receives Equity Investment from DSM

ZeaVision Receives Equity Investment from DSM

ZeaVision received a strategic equity investment from DSM Venturing, the corporate venture arm of Royal DSM, global life sciences and material sciences company.

ST. LOUIS—ZeaVision received a strategic equity investment from DSM Venturing, the corporate venture arm of Royal DSM, global life sciences and material sciences company.

"DSM has a long history of excellence and innovation in the nutrition industry," said Chris Barber, ZeaVision president. “We are pleased to welcome DSM as a strategic investor, which offers unique potential to strengthen ZeaVision's leadership position in the ocular nutrition market."

Will Black, vice president of marketing for DSM nutritional products, also added that ZeaVision “made a significant contribution to expand research and scientific understanding" regarding eye health.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish